Physiopathology of Spine Metastasis

The metastasis is the spread of cancer from one part of the body to another. Two-thirds of patients with cancer will develop bone metastasis. Breast, prostate and lung cancer are responsible for more than 80% of cases of metastatic bone disease. The spine is the most common site of bone metastasis. A spinal metastasis may cause pain, instability and neurological injuries. The diffusion through Batson venous system is the principal process of spinal metastasis, but the dissemination is possible also through arterial and lymphatic system or by contiguity. Once cancer cells have invaded the bone, they produce growth factors that stimulate osteoblastic or osteolytic activity resulting in bone remodeling with release of other growth factors that lead to a vicious cycle of bone destruction and growth of local tumour.

[1]  S. Rabbani,et al.  Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. , 1994, Cancer research.

[2]  T. Rosol Pathogenesis of Bone Metastases: Role of Tumor‐Related Proteins , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  L. Hofbauer,et al.  The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[4]  H. V. Crock,et al.  Observations on the venous drainage of the human vertebral body. , 1973, Journal of Bone and Joint Surgery-british Volume.

[5]  W. Stetler-Stevenson,et al.  Matrix metalloproteinases and metastasis , 1999, Cancer Chemotherapy and Pharmacology.

[6]  R. Nusse,et al.  The Wnt signaling pathway in development and disease. , 2004, Annual review of cell and developmental biology.

[7]  V. Kähäri,et al.  Matrix metalloproteinases in tumor invasion , 2000, Cellular and Molecular Life Sciences CMLS.

[8]  D. Togawa,et al.  The Pathophysiology of Spinal Metastases , 2006 .

[9]  J. Greenberger The pathophysiology and management of spine metastasis from lung cancer , 2005, Journal of Neuro-Oncology.

[10]  J. Izbicki,et al.  Early metastasis of human solid tumours: expression of cell adhesion molecules. , 1995, Ciba Foundation symposium.

[11]  D. Connolly,et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.

[12]  E. Bauer,et al.  Role of the extracellular matrix in the degradation of connective tissue , 2004, Archives of Dermatological Research.

[13]  Jing Wu,et al.  Use of zoledronate to treat osteoblastic versus osteolytic lesions in a severe-combined-immunodeficient mouse model. , 2002, Cancer research.

[14]  D. R. Coman,et al.  The role of the vertebral venous system in the metastasis of cancer to the spinal column. Experiments with tumor‐cell suspensions in rats and rabbits , 1951, Cancer.

[15]  E. Bonucci Physiopathology of cancer metastases in bone and of the changes they induce in bone remodeling , 2002 .

[16]  K. Yonenobu,et al.  Orthopaedic management of spinal metastases. , 1995, Clinical orthopaedics and related research.

[17]  V. Kähäri,et al.  Matrix metalloproteinases in squamous cell carcinoma. , 2000, Histology and histopathology.

[18]  G. T. Krishnamurthy,et al.  Distribution pattern of metastatic bone disease. A need for total body skeletal image. , 1977, JAMA.

[19]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[20]  J. Hayman,et al.  Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. , 1991, Cancer research.

[21]  E. Keller,et al.  The role of Wnts in bone metastases , 2007, Cancer and Metastasis Reviews.

[22]  Y. DeClerck Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. , 2000, European journal of cancer.

[23]  G. David Roodman Role of stromal‐derived cytokines and growth factors in bone metastasis , 2003, Cancer.

[24]  Judith P. Johnson Cell adhesion molecules of the immunoglobulin supergene family and their role in malignant transformation and progression to metastatic disease , 1991, Cancer and Metastasis Reviews.

[25]  G. Powell,et al.  Localization of parathyroid hormone‐related protein mrna expression in breast cancer and metastatic lesions by in situ hybridization , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  N. Clarke,et al.  Parathyroid hormone related peptide and receptor expression in paired primary prostate cancer and bone metastases , 2002, British Journal of Cancer.

[27]  G. Tuszynski,et al.  The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis , 2009, Pathology Oncology Research.

[28]  J. Heimans,et al.  Do metastases in vertebrae begin in the body or the pedicles? Imaging study in 45 patients. , 1992, AJR. American journal of roentgenology.

[29]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[30]  James H. Doroshow,et al.  Abeloff's Clinical Oncology , 2013 .

[31]  R. Coleman Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity , 2006, Clinical Cancer Research.

[32]  K. Honn,et al.  Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix , 1992, Cancer and Metastasis Reviews.

[33]  R. Sanderson,et al.  Matrix Metalloproteinases in Multiple Myeloma , 2000, Leukemia & lymphoma.

[34]  F. Orr,et al.  Pathophysiologic interactions in skeletal metastasis , 2000, Cancer.

[35]  J. Chirgwin,et al.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Chirgwin,et al.  Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases , 2007, Cancer and Metastasis Reviews.

[37]  J. Posner,et al.  Epidural spinal cord compression from metastatic tumor: Diagnosis and treatment , 1978, Annals of neurology.

[38]  T. Guise,et al.  Cancer and bone. , 1998, Endocrine reviews.

[39]  O. Batson The function of the vertebral veins and their role in the spread of metastases. 1940. , 1995, Clinical orthopaedics and related research.

[40]  Z. Werb,et al.  The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. , 2001, Trends in cell biology.

[41]  R. Fechner Bone tumors: Clinical, radiologic and pathologic correlations: Joseph M. Mirra, Philadelphia, PA, Lea & Febiger, 1989, 1,833 pages (volumes 1 & 2 combined), $250 , 1990 .

[42]  A. Angelucci,et al.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines , 2004, Clinical & Experimental Metastasis.

[43]  Jonathan B. Cohen Tumors and Tumorous Conditions of the Bones and Joints. Henry L. Jaffe, M.D. Philadelphia, Lea and Febiger, 1958. $18.50 , 1958 .

[44]  W. Stetler-Stevenson,et al.  The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. , 1994, The European respiratory journal.

[45]  Y. M. Yang,et al.  Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption , 2000, British Journal of Cancer.

[46]  K. Harrington Orthopedic surgical management of skeletal complications of malignancy , 1997, Cancer.

[47]  S. Rabbani,et al.  Molecular basis of the spectrum of skeletal complications of neoplasia , 2000, Cancer.

[48]  B. Gainor,et al.  A Profile of Metastatic Carcinoma of the Spine , 1985, Spine.

[49]  A. Lipton Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention. , 2004, The journal of supportive oncology.

[50]  P. Siegel,et al.  Breast cancer-derived factors facilitate osteolytic bone metastasis. , 2006, Bulletin du cancer.

[51]  O. V. Batson THE RÔLE OF THE VERTEBRAL VEINS IN METASTATIC PROCESSES , 1942 .

[52]  S. Ménard,et al.  Expression of Bone Sialoprotein in Human Lung Cancer , 1997, Calcified Tissue International.

[53]  K. Honn,et al.  Adhesion molecules and tumor metastasis: an update. , 1994, Invasion & metastasis.

[54]  F. Mansfield,et al.  One-stage posterolateral decompression and stabilization for primary and metastatic vertebral tumors in the thoracic and lumbar spine. , 1989, Journal of neurosurgery.

[55]  Zuxiong Chen,et al.  Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. , 1996, The Journal of urology.

[56]  K P Dingemans,et al.  Mechanisms of metastasis. , 1979, Biochimica et biophysica acta.

[57]  E. Ogata,et al.  Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro. , 2000, Biochemical and biophysical research communications.

[58]  O. V. Batson THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASES , 1940, Annals of surgery.

[59]  I. Stamenkovic Matrix metalloproteinases in tumor invasion and metastasis. , 2000, Seminars in cancer biology.

[60]  P. Black Spinal metastasis: current status and recommended guidelines for management. , 1979, Neurosurgery.

[61]  G. Roodman,et al.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. , 1995, The Journal of clinical investigation.

[62]  C. Galasko Mechanisms of bone destruction in the development of skeletal metastases , 1976, Nature.

[63]  N. Clarke,et al.  Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies , 2002, British Journal of Cancer.

[64]  E. Baldi,et al.  Endothelin‐1 production by prostate cancer cell lines is up‐regulated by factors involved in cancer progression and down‐regulated by androgens , 2001, The Prostate.

[65]  J. Nelson,et al.  Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate , 1995, Nature Medicine.

[66]  L. Liotta,et al.  Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  V. Castronovo,et al.  Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. , 2000, Circulation research.

[68]  L. Weiss,et al.  Organ vascularity and metastatic frequency. , 1980, The American journal of pathology.

[69]  N. Clarke,et al.  Morphometric evidence for bone resorption and replacement in prostate cancer. , 1991, British journal of urology.

[70]  Yi Zhang,et al.  Genes associated with breast cancer metastatic to bone. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  R. Hutter,et al.  Neoplasms of the spine in the aged. , 1963, Clinical orthopaedics and related research.

[72]  G. Roodman Mechanisms of bone metastasis. , 2004, Discovery medicine.

[73]  L. Liaw,et al.  Functions of the extracellular matrix and matrix degrading proteases during tumor progression. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[74]  R. Baggs,et al.  Pathogenesis of vertebral metastasis and epidural spinal cord compression , 1990, Cancer.

[75]  U. G. Dailey Cancer,Facts and Figures about. , 2022, Journal of the National Medical Association.

[76]  G. Mundy Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[77]  K. Kelly,et al.  Mechanisms of cancer metastasis to the bone , 2005, Cell Research.

[78]  J. Glowacki,et al.  Stromal Cell-Mediated Stimulation of Osteoclastogenesis , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[79]  B. Fingleton,et al.  Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  S. Zucker,et al.  Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. , 2001, Drug discovery today.

[81]  J. Starkey Cell-matrix interactions during tumor invasion , 1990, Cancer and Metastasis Reviews.

[82]  M. Stack,et al.  Membrane associated matrix metalloproteinases in metastasis. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[83]  J. Posner,et al.  Management of spinal epidural metastases. , 1983, Clinical neurosurgery.

[84]  N Sundaresan,et al.  Treatment of neoplastic spinal cord compression: results of a prospective study. , 1991, Neurosurgery.

[85]  Jonathan N Grauer,et al.  Metastatic Disease of the Spine , 2006, The Journal of the American Academy of Orthopaedic Surgeons.

[86]  M. Duffy The role of proteolytic enzymes in cancer invasion and metastasis , 1992, Clinical & Experimental Metastasis.

[87]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.